TNF and ulcerative colitis: Golimumab is a fully humanized anti-TNFα monoclonal antibody that is approved for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and moderate to severe ulcerative colitis, but not for JIA-U.